During the last session, Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s traded shares were 0.84 million, with the beta value of the company hitting 1.28. At the end of the trading day, the stock’s price was $3.75, reflecting an intraday gain of 8.07% or $0.28. The 52-week high for the CKPT share is $3.97, that puts it down -5.87 from that peak though still a striking 63.73% gain since the share price plummeted to a 52-week low of $1.36. The company’s market capitalization is $183.12M, and the average intraday trading volume over the past 10 days was 0.76 million shares, and the average trade volume was 667.65K shares over the past three months.
Checkpoint Therapeutics Inc (CKPT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. CKPT has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Checkpoint Therapeutics Inc (NASDAQ:CKPT) trade information
Checkpoint Therapeutics Inc (CKPT) registered a 8.07% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 8.07% in intraday trading to $3.75, hitting a weekly high. The stock’s 5-day price performance is 9.33%, and it has moved by 9.01% in 30 days. Based on these gigs, the overall price performance for the year is 79.43%. The short interest in Checkpoint Therapeutics Inc (NASDAQ:CKPT) is 5.56 million shares and it means that shorts have 5.7 day(s) to cover.
Checkpoint Therapeutics Inc (CKPT) estimates and forecasts
Statistics show that Checkpoint Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Checkpoint Therapeutics Inc (CKPT) shares have gone up 103.80% during the last six months, with a year-to-date growth rate more than the industry average at 71.29% against 17.90. In the rating firms’ projections, revenue will decrease -76.70% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 10.33k as predicted by 3 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 4.53M by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 26.32%. While earnings are projected to return 71.45% in 2024.
CKPT Dividends
Checkpoint Therapeutics Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s Major holders
Checkpoint Therapeutics Inc insiders own 15.52% of total outstanding shares while institutional holders control 13.91%, with the float percentage being 16.47%.
Also, the Mutual Funds coming in first place with the largest holdings of Checkpoint Therapeutics Inc (CKPT) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Jun 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 1.09 shares. This amounts to just over 2.27 percent of the company’s overall shares, with a $4.1 million market value. The same data shows that the other fund manager holds slightly less at 242.15, or about 0.50% of the stock, which is worth about $0.91 million.
